Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Obesity 6Sexual Dysfunction, Physiological 5Dyspnea 5Neoplasms 3Motor Activity 3Recurrence 2Neoplasm Metastasis 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Prediabetic State 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Obesity, Morbid 1Non-alcoholic Fatty Liver Disease 1Mucositis 1Insulin Resistance 1Hyperinsulinism 1Hematologic Diseases 1Esophagitis 1Endometrial Neoplasms 1Diabetes Mellitus 1Depression 1Constipation 1Colorectal Neoplasms 1Anxiety Disorders 1

Interventions

Surveys and Questionnaires 1Glutamine 1Dietary Supplements 1Alginates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophagitis × Surveys and Questionnaires × Other × Clear all
NCT01952847 2022-06-15

Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis

M.D. Anderson Cancer Center

Phase 3 Terminated
77 enrolled 28 charts
Other

Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡